Psyence Biomedical Ltd.
PBM
NASDAQ Capital Market4.54
USD
+0.11
- -
Total Valuation
Psyence Biomedical Ltd. carries a market capitalization of 86,346.00, placing it among publicly traded companies globally.
| Market Cap | 86,346.00 |
| Enterprise Value | N/A |
Stock Price Statistics
Psyence Biomedical Ltd.'s stock has declined approximately -73.54312% over the past 52 weeks. The 50-day moving average sits at 3.47, while the 200-day moving average is 13.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | -73.54312% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 13.30 |
| Average Volume (20 Days) | N/A |
Stock Splits
Psyence Biomedical Ltd.'s most recent stock split took place on February 2, 2026 with a 6:1 split ratio.
| Last Split Date | 2/2/2026 |
| Split Ratio | 6:1 |